Janus kinase inhibitor tofacitinib successfully treated palmoplantar pustulosis after switching from secukinumab: A case report and review of the literature
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.112762 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Yiming Fan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Janus Kinase Inhibitors, Piperidines, Psoriasis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Palmoplantar pustulosis (PPP) is a chronic inflammatory recurrent disease characterized by sterile pustules involving palms and/or feet. Presently, there are no standard recommended treatment regimens. Tofacitinib is an oral Janus kinase (JAK) inhibitor, mainly acts on JAK 1 and 3 and has been approved for the treatment of rheumatoid arthritis in adults. Herein, we present a case of a patient with PPP who did not respond to IL-17A inhibitor secukinumab but was successfully treated by the JAK inhibitor tofacitinib.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China.
- Department of Dermatology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China. Electronic address: swyinrui@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Fan, Y., & Yin, R. (2024). Janus kinase inhibitor tofacitinib successfully treated palmoplantar pustulosis after switching from secukinumab: A case report and review of the literature. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112762
Vancouver
Fan Y, Yin R. Janus kinase inhibitor tofacitinib successfully treated palmoplantar pustulosis after switching from secukinumab: A case report and review of the literature. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112762
BibTeX
@article{Fan2024,
author = {Fan, Yiming and Yin, Rui},
title = {Janus kinase inhibitor tofacitinib successfully treated palmoplantar pustulosis after switching from secukinumab: A case report and review of the literature},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.112762}
}
EUVIMED